Trulieve Cannabis Corp.
General ticker "TCNNF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.3B (TTM average)
Trulieve Cannabis Corp. follows the US Stock Market performance with the rate: 35.4%.
Estimated limits based on current volatility of 5.8%: low 8.08$, high 9.07$
Factors to consider:
- Total employees count: 6000 (+11.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Federal law enforcement, Regulatory and compliance, Market competition, Strategic risks and growth management, Product liability
- Earnings for 15 months up through Q1 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.06$, 7.72$]
- 2025-12-31 to 2026-12-31 estimated range: [2.50$, 6.32$]
Financial Metrics affecting the TCNNF estimates:
- Positive: with PPE of -6.3 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 29.29 > 12.93
- Negative: negative Net income
- Positive: 7.57 < Operating profit margin, % of 8.24
- Negative: Investing cash flow per share per price, % of -22.29 <= -14.27
- Negative: 42.57 < Shareholder equity ratio, % of 43.52 <= 64.23
- Positive: Industry inventory ratio change (median), % of -1.60 <= -0.15
- Positive: Inventory ratio change, % of 0 <= 0
Short-term TCNNF quotes
Long-term TCNNF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,129.19MM | $1,186.49MM | $1,181.18MM |
| Operating Expenses | $1,350.81MM | $1,088.71MM | $1,037.68MM |
| Operating Income | $-221.61MM | $97.78MM | $143.50MM |
| Non-Operating Income | $-62.92MM | $-55.07MM | $-52.02MM |
| Interest Expense | $81.57MM | $62.19MM | $63.45MM |
| Income(Loss) | $-284.54MM | $42.71MM | $91.47MM |
| Taxes | $151.36MM | $197.59MM | $208.11MM |
| Other Income(Loss) | $-97.24MM | $-5.70MM | $-5.61MM |
| Net Income(Loss)* | $-527.99MM | $-155.10MM | $-116.38MM |
| Stockholders Equity | $1,408.61MM | $1,249.03MM | $1,143.01MM |
| Assets | $2,729.05MM | $2,870.27MM | $2,696.10MM |
| Operating Cash Flow | $201.84MM | $271.48MM | $272.82MM |
| Capital expenditure | $55.49MM | $121.52MM | $44.97MM |
| Investing Cash Flow | $-37.47MM | $-206.62MM | $13.50MM |
| Financing Cash Flow | $-175.59MM | $-33.44MM | $-270.50MM |
| Earnings Per Share** | $-2.79 | $-0.82 | $-0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.